关注
Jermaine Jones
Jermaine Jones
Associate Professor of Clinical Neurobiology (in Psychiatry), Columbia University Medical Center
在 nyspi.columbia.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Polydrug abuse: a review of opioid and benzodiazepine combination use
JD Jones, S Mogali, SD Comer
Drug and alcohol dependence 125 (1-2), 8-18, 2012
7762012
Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use
JA Gudin, S Mogali, JD Jones, SD Comer
Postgraduate medicine 125 (4), 115-130, 2013
2842013
Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial
SL Walsh, SD Comer, MR Lofwall, B Vince, N Levy-Cooperman, D Kelsh, ...
JAMA psychiatry 74 (9), 894-902, 2017
1032017
Glial and neuroinflammatory targets for treating substance use disorders
RK Bachtell, JD Jones, KG Heinzerling, PM Beardsley, SD Comer
Drug and alcohol dependence 180, 156-170, 2017
1022017
The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid‐dependent volunteers
ZD Cooper, KW Johnson, M Pavlicova, A Glass, SK Vosburg, MA Sullivan, ...
Addiction biology 21 (4), 895-903, 2016
942016
Effects of ibudilast on the subjective, reinforcing, and analgesic effects of oxycodone in recently detoxified adults with opioid dependence
VE Metz, JD Jones, J Manubay, MA Sullivan, S Mogali, A Segoshi, ...
Neuropsychopharmacology 42 (9), 1825-1832, 2017
762017
No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone
JD Jones, A Campbell, VE Metz, SD Comer
Addictive behaviors 71, 104-106, 2017
722017
The pharmacogenetics of alcohol use disorder
JD Jones, SD Comer, HR Kranzler
Alcoholism: Clinical and Experimental Research 39 (3), 391-402, 2015
702015
Sex differences among opioid-abusing patients with chronic pain in a clinical trial
J Manubay, J Davidson, S Vosburg, J Jones, S Comer, M Sullivan
Journal of addiction medicine 9 (1), 46-52, 2015
682015
Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users
JD Jones, P Roux, S Stancliff, W Matthews, SD Comer
International Journal of Drug Policy 25 (1), 166-170, 2014
652014
A review of human drug self-administration procedures
JD Jones, SD Comer
Behavioural pharmacology 24 (5 and 6), 384-395, 2013
642013
Assessment of a formulation designed to be crush-resistant in prescription opioid abusers
SK Vosburg, JD Jones, JM Manubay, JB Ashworth, IH Benedek, ...
Drug and alcohol dependence 126 (1-2), 206-215, 2012
622012
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of …
P Roux, MA Sullivan, J Cohen, L Fugon, JD Jones, SK Vosburg, ...
PAIN® 154 (8), 1442-1448, 2013
572013
How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies
J Neale, C Brown, ANC Campbell, JD Jones, VE Metz, J Strang, ...
Addiction 114 (4), 708-718, 2019
542019
Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances
ZD Cooper, JD Jones, SD Comer
Expert opinion on investigational drugs 21 (2), 169-178, 2012
542012
Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers
SD Comer, S Mogali, PA Saccone, P Askalsky, D Martinez, EA Walker, ...
Neuropsychopharmacology 38 (12), 2427-2438, 2013
532013
A comparison among tapentadol tamper‐resistant formulations (TRF) and OxyContin® (non‐TRF) in prescription opioid abusers
SK Vosburg, JD Jones, JM Manubay, JB Ashworth, DY Shapiro, ...
Addiction 108 (6), 1095-1106, 2013
522013
Chronic pain and opioid abuse: Factors associated with health‐related quality of life
JD Jones, JS Vogelman, R Luba, M Mumtaz, SD Comer
The American journal on addictions 26 (8), 815-821, 2017
442017
Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine‐maintained heroin users
JD Jones, MA Sullivan, SK Vosburg, JM Manubay, S Mogali, V Metz, ...
Addiction biology 20 (4), 784-798, 2015
412015
A review of pharmacogenetic studies of substance-related disorders
JD Jones, SD Comer
Drug and alcohol dependence 152, 1-14, 2015
382015
系统目前无法执行此操作,请稍后再试。
文章 1–20